ANTHONY KNATT: Open Payments
NPI 1922616085 · CROWLEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 31 payments from 9 companies in 2025. Trend: 2023 $309 · 2024 $87 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $214 |
| Janssen Pharmaceuticals, Inc | 6 | $171 |
| Teva Pharmaceuticals USA, Inc. | 3 | $153 |
| Neurocrine BioSciences, Inc. | 3 | $85 |
| Alkermes, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: COBENFY, INVEGA, AUSTEDO XR, INGREZZA, UZEDY, ABILIFY ASIMTUFII, ARISTADA, VRAYLAR.
Industry payments across LA — which companies pay providers there.
